Publications in collaboration with researchers from Università degli Studi di Brescia (38)

2024

  1. Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

    European Journal of Heart Failure

  2. Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure

    American Heart Journal, Vol. 267, pp. 52-61

  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  4. Reliability of large language models in managing odontogenic sinusitis clinical scenarios: a preliminary multidisciplinary evaluation

    European Archives of Oto-Rhino-Laryngology

2023

  1. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry

    European journal of preventive cardiology, Vol. 30, Núm. 13, pp. 1346-1358

  2. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma

    Head and Neck, Vol. 45, Núm. 9, pp. 2274-2293

  3. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 457-468

  4. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry

    European Heart Journal, Vol. 44, Núm. 17, pp. 1526-1529

  5. Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1049-1060

  6. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1061-1071

  7. Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery

    European Journal of Heart Failure, Vol. 25, Núm. 12, pp. 2316-2330

  8. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial

    JACC: Heart Failure, Vol. 11, Núm. 12, pp. 1729-1738

2022

  1. Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial

    JAMA Cardiology, Vol. 7, Núm. 1, pp. 26-34

  2. Gracilis free flap in head and neck reconstruction beyond facial palsy reanimation

    Acta Otorrinolaringologica Espanola, Vol. 73, Núm. 5, pp. 310-322

  3. Machine Learning Algorithms as a Computer-Assisted Decision Tool for Oral Cancer Prognosis and Management Decisions: A Systematic Review

    ORL, Vol. 84, Núm. 4, pp. 278-288

  4. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

    European Journal of Heart Failure, Vol. 24, Núm. 1, pp. 143-168

  5. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

    European journal of preventive cardiology, Vol. 29, Núm. 1, pp. 275-300

2021

  1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal, Vol. 42, Núm. 36, pp. 3599-3726

  2. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

  3. Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary

    European Journal of Heart Failure, Vol. 23, Núm. 10, pp. 1597-1609